The US's decision to halt most foreign aid this year has been a “systemic shock” to the fight against AIDS, according to ...

Merck on Thursday said the application covers the investigational, once-daily, oral two-drug regimen for adults with HIV-1 infection that is virologically suppressed on antiretroviral therapy. The ...

Through a strategic, non-profit agreement, Gilead will supply up to two million doses of the long-acting HIV prevention drug ...

In a report released on Thursday, the UN body in charge of fighting HIV/Aids does not single out the US, but says that ...

UNAIDS emphasizes that every dollar invested in the HIV response not only saves lives but strengthens health systems and promotes broader development goals. Since the start of the epidemic, 26.9 ...

A new U.N. AIDS agency report says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global effort ...

A historic funding crisis is threatening to unravel decades of progress unless countries can make radical shifts to HIV programming and funding. The report highlights the impact that the sudden, large ...

The halt to US foreign aid is a "ticking time bomb" that could reverse decades of hard-fought gains in the fight against AIDS ...

Some poorer nations hit by cuts in HIV/AIDS funding from rich donors have boosted their own spending in response, but not ...

As reported by The Hollywood Reporter, Tina Knowles is expected to be honored with the Elizabeth Taylor Commitment to End AIDS Award at the Elizabeth Taylor Night of Compassion. Organized by its ...

In the mid-1990s, my then-husband passed away from complications of HIV/AIDS. From the time he was diagnosed until he died, all of us, friends and family, but most of all, ...

Gilead Sciences (GILD) stock in focus as the company joins The Global Fund to expand access to lenacapavir, an HIV PrEP ...